Anna Hanzlíková

Founder at Independent

Speaker

Anna Hanzlikova holds an M.D. title from 1st Faculty of Medicine at Charles University in Prague. She explored and gained experience at several positions in project management, marketing and for the last 17 years in global regulatory affairs, at regional or global level, with responsibility for various regions.

During her career at Sanofi, she was responsible for international regional teams in regions like Asia, Latin America, Middle East and Africa. She helped to develop regional portfolios as well as to integrate new teams from companies acquired by Sanofi in these regions. Broadening of her geographical scope into Europe and Russian speaking countries as well as type of products brought her PRO.MED.CS, a Czech based family-owned pharmaceutical company focused on gastrointestinal portfolio, where she acted also as deputy R&D director, in parallel to her Global Regulatory role. During the peak of pandemic, Anna accepted an offer from Novavax, to take lead in new marketing authorisation efforts and end-to-end regulatory activities for a protein-based Covid-19 adjuvanted vaccine in Europe, Asia and Middle East as well as with WHO. Most recently, Anna established a consultancy company A-REG, focused on regulatory and related aspects, mainly for biological and innovative products.

Anna has build and led small to mid sized international regulatory teams, with focus at all – global, regional and affiliate level, and an emphasis on good communication, multicultural diversity, excellence in organisation and successful regulatory tasks delivery. She enjoys working and growing with the team as well as creative work on regulatory strategies or authoring of some regulatory documents.